Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 2 Urinary Tract Infections 1 Tissue Adhesions 1 Polyps 1 Non-Muscle Invasive Bladder Neoplasms 1 Neutropenia 1 Neoplasms 1 Myoma 1 Multiple Myeloma 1 Infections 1 Hematologic Neoplasms 1 Hearing Loss 1 Febrile Neutropenia 1 Endometritis 1 Ear Neoplasms 1 Cystitis 1

Interventions

Ankle Brachial Index 2 Acetylcysteine 2 sodium thiosulfate 1 Tomography, X-Ray Computed 1 Saline Solution 1 Ringer's Lactate 1 Radiosurgery 1 Platinum 1 Ofloxacin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Hearing Tests 1 Hearing 1 Genetic Association Studies 1 Ear Protective Devices 1 Cisplatin 1 Carboplatin 1 Audiometry, Pure-Tone 1 Acoustic Impedance Tests 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hearing Loss × Ofloxacin × Clear all

NCT00584155 2015-05-27

Protection From Cisplatin Ototoxicity by Lactated Ringers

University of Oklahoma

Phase 1 Withdrawn

Ear Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡